Healthcare

The Emergency Center Arizona (TEA) Rebrands to Canyon State Emergency Partners (CSEP) to Reflect Local Dedication and Physician-Led Model

PHOENIX, ARIZONA / ACCESS Newswire / December 11, 2025 / The Emergency Center Arizona (TEA), one of the largest physician-led…

2 weeks ago

AIML Announces Engagement of Guerilla Capital for Communications and Investor Outreach Efforts

TORONTO, ON / ACCESS Newswire / December 11, 2025 / AI/ML Innovations Inc. (CSE:AIML) ("AIML" or the "Company") is pleased…

2 weeks ago

Zomedica Announces Collaboration with Prime Video as Assisi Loop(R) Products Appear in New Holiday Film Merv

The collaboration highlights Zomedica's commitment to expanding pet wellness education as Assisi Loop technology is featured in the highly anticipated…

2 weeks ago

60 Degrees Pharmaceuticals Announces Expansion of ARAKODA® Sales and Marketing in 2026

6-month commercial pilot demonstrated increasing demand among prescribersExpansion plan includes doubling the number of sales reps, a new GoodRx partnership,…

2 weeks ago

NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx

NEXGEL shareholders will receive a non-dilutive 19.99% equity interest in NexGelRx up to $8 million of capital investment in spin-off…

2 weeks ago

Stryker declares an $0.88 per share quarterly dividend

Portage, Michigan, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly…

2 weeks ago

PatchMD Launches New Dopamine Support Patch for Natural Mood and Focus Support

Original Vitamin Patch Pioneer Introduces Comprehensive Dopamine Precursor Formula Backed by Clinical ResearchLas Vegas, NV, Dec. 11, 2025 (GLOBE NEWSWIRE)…

2 weeks ago

InflaRx Announces International Nonproprietary Name of “Izicopan” for INF904

JENA, Germany, Dec. 11, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting…

2 weeks ago

Opus Genetics to Present at the J.P. Morgan 2026 Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”),…

2 weeks ago